Regression of peripapillary choroidal neovascular membrane in a patient with sarcoidosis after oral steroid therapy  by Shoughy, Samir S. et al.
Saudi Journal of Ophthalmology (2014) 28, 160–162Case ReportRegression of peripapillary choroidal neovascular membrane
in a patient with sarcoidosis after oral steroid therapyIPeer review under responsibility
of Saudi Ophthalmological Society,
King Saud University Production and hosting by Elsevier
Access this article onlin
www.saudiophthaljourn
www.sciencedirect.com
Received 27 January 2014; received in revised form 18 February 2014; accepted 25 February 2014; available online 6 March 2014.
a The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, Saudi Arabia
b Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
c The Wilmer Ophthalmological Institute of The Johns Hopkins University, School of Medicine, Baltimore, MD, USA
⇑ Corresponding author at: The Eye Center and The Eye Foundation for Research in Ophthalmology, 241 Makkah Road, P.O. Box 55307, Riyadh
Saudi Arabia. Tel.: +966 14623094; fax: +966 14629675.
e-mail address: k.tabbara@nesma.net.sa (K.F. Tabbara).
q This Study was supported in part by a Special Fund from The Eye Center and The Eye Foundation for Research in Ophthalmology, Riyadh, Saudi Arabia.Samir S. Shoughy, MD, FRCS a; Mahmoud O. Jaroudi, MD a; Khalid F. Tabbara, MD, ABO, FRCOphth (Ed) a,b,c,⇑AbstractChoroidal neovascular membrane (CNV) may occur in patients with posterior uveitis. Treatment of patients with corticosteroids
induces regression of the inflammation in the posterior pole with downregulation of many cytokines including vascular endothelial
growth factors. We report herewith, a case of biopsy proven sarcoidosis that developed posterior uveitis and peripapillary CNV
membrane and subretinal hemorrhage with fluid. The patient was treated with systemic steroids. She demonstrated progressive
regression of the CNV membrane and complete resolution of the subretinal hemorrhage and fluids. In conclusion, control of the
posterior segment inflammation is crucial in the resolution of the CNV membrane in uveitis and the intravitreal anti-vascular
endothelial growth factor may not be always indicated.
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Sarcoidosis is a chronic multisystem inflammatory disorder
of unknown etiology. The disease is characterized by non-
caseating granulomata that affect many organs, including
the lungs, lymph nodes, skin, heart, liver, muscles and eye.
Ocular lesions are common among patients with sarcoidosis.1
Choroidal neovascular (CNV) membrane occurs rarely in pa-
tients with sarcoidosis, but can be vision-threatening when
it involves peripapillary locations.2–4 Peripapillary CNV mem-
brane is characterized clinically by the presence of a CNV
membrane adjacent to the disc which may lead to subretinal
hemorrhage, fluid, or exudates.5 We report herewith, a case
of peripapillary CNV membrane in a patient with sarcoidosis
which showed regression after oral steroid therapy.Case report
A 40-year-old woman presented to The Eye Center,
Riyadh, KSA with itching and dryness of both eyes for long
duration. Her best corrected visual acuity (BCVA) was 20/60
in the right eye and 20/30 in the left eye. The decrease of vi-
sion in the right eye was due to anisometropic amblyopia.
Schirmer test was 0 mm in both eyes. Slit-lamp biomicros-
copy and funduscopy were normal bilaterally. She was diag-
nosed with dry eye syndrome and was treated with topical
lubricants and the application of punctal plugs. On her follow
up visit, she came complaining of increased irritation in both
eyes and xerostomia. A labial biopsy of the accessory salivary
glands was performed by one of us (KFT) and tissue
specimens were subjected to histopathologic evaluation.e:
al.com
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Figure 1. Koeppe nodules.
Figure 2. Peripapillary choroidal neovascular membrane with adjacent
hemorrhage.
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consistent with sarcoidosis. The granuloma was composed
of epithelioid histiocytes, multinucleated giant cells and
mononuclear cells. There were no lymphoepithelial lesions
to suggest Sjögren’s syndrome or malignancy. Modified
Ziehl–Neelsen stain was negative for mycobacteria.
Later, the patient developed anterior granulomatous uve-
itis in the right eye with mutton-fat keratic precipitates and
three large Koeppe nodules (Fig. 1). She was referred to a
pulmonologist for further evaluation and was found to haveFigure 3. Optical Coherence Tomography (OCT) showing subremild restriction of the lung function tests. Chest X-ray re-
vealed bilateral hilar lymphadenopathy. Serum Alkaline phos-
phatase was 300 U/L (normal range 30–125). Percutaneous
liver biopsy was done and histopathological evaluation of
biopsy specimens was consistent with sarcoidosis. The pa-
tient was diagnosed with sarcoidosis affecting the lungs
and liver.
Subsequently, the patient presented with the history of
blurring of vision in the left eye. Her best corrected visual
acuity (BCVA) was 20/60 in the right eye and 20/30 in the left
eye. Flaremetry with KOWA FM-600 Laser Flaremeter was
10 photons/ms in the right eye and 8 photons/ms in the left
eye. Biomicroscopy revealed anterior granulomatous uveitis
in both eyes. Funduscopy of the right eye was normal and
the left eye revealed the peripapillary CNV membrane with
subjacent hemorrhage (Fig. 2). Optical coherence tomogra-
phy was done and revealed subretinal fluid adjacent to the
optic nerve head and dry macula with smooth vitreoretinal
interface (Fig. 3). Fundus fluorescein angiography showed
staining of the CNV membrane and adjacent hypofluores-
cence corresponding to the area of hemorrhage.
The patient was given prednisone 20 mg orally daily and
topical prednisolone acetate to both eyes. She was main-
tained on 10 mg oral prednisone. After two months the
CNV membrane started to regress in size and areas of hem-
orrhages were noted to clear. Funduscopy of the left eye re-
vealed marked regression of the CNV membrane and
complete resolution of the peripapillary hemorrhages. Oral
prednisone was tapered and discontinued. The patient was
followed-up for a period of one year with no recurrence of
the CNV membrane (Fig. 4).Discussion
Peripapillary CNV membrane may occur in association
with several conditions including age-related macular degen-
eration which is the most common cause (45.2% of the cases),
multifocal choroiditis (4.3%), angioid streaks (2.6%), histo-
plasmosis (1.7%), choroidal osteoma (1.7%), optic disc drusen
(0.9%), and congenital disc anomaly (0.9%).4 In cases of uve-
itis, chronic disc edema may present prior to the onset of the
disease. Chronic disc swelling may induce peripapillary CNV
membrane by increasing the potential space between thetinal fluid adjacent to the optic nerve head and dry macula.
Figure 4. Before treatment (A); after treatment (B).
162 S.S. Shoughy et al.Bruch’s membrane and the swollen disc tissue facilitating in-
growth of choroidal vessels around the termination of the
Bruch’s membrane. Alternatively, chronic disc edema may re-
sult in the deformation of the peripapillary Bruch’s mem-
brane leading to breaks in the Bruch’s membrane which
allows ingrowth of the choroidal neovessels under the retinal
pigment epithelium (RPE).6 Clinically, peripapillary CNV
membrane is characterized by the presence of a CNV
membrane adjacent to the optic nerve producing subretinal
hemorrhage, fluid, and/or exudates.6 Several treatment
modalities for sarcoid-related peripapillary CNV membrane
have been reported. These include systemic, oral and perioc-
ular steroids, argon laser photocoagulation and intravitreal
anti-vascular endothelial growth factor agents.7
In our case, the initial presentation of ocular sarcoidosis
was with signs and symptoms of dry eye syndrome that were
treated with topical lubricants and punctal plugs. Later,
patient developed xerostomia and labial biopsy of the acces-
sory salivary glands was performed. The biopsy revealed sar-
coidosis that was subsequently confirmed by a biopsy of the
liver. The diagnosis of systemic sarcoidosis was established in
our patient prior to the development of ocular manifestations
of the disease. Ocular involvement started with anterior gran-
ulomatous uveitis without posterior segment affection. Peri-
papillary CNV membrane developed later in the left eye.
The CNV membrane responded to oral prednisone therapy
without the need for intravitreal or periocular injections.
CNV membrane in cases of sarcoidosis was found to
respond well to oral steroids.8 Corticosteroids induce regres-
sion of the inflammation in the posterior pole in cases of
posterior uveitis with downregulation of many cytokinesincluding VEGF. The good response to oral prednisone seen
in our patient emphasizes the importance of trial of oral
immunosuppression before considering periocular injections
of steroids or intravitreal injections of vascular endothelial
growth factor inhibitors.
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